Austin, TX, United States of America

Dharmika Lansakara-P

This inventor holds 1 USPTO granted patent. Top assignee: The University of Texas System. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Dharmika Lansakara-P. Retrieved from https://idiyas.com/inventor/dharmika-lansakara-p

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Dharmika Lansakara-P: Innovator in Nucleobase Analogue Derivatives

Introduction

Dharmika Lansakara-P is an accomplished inventor based in Austin, TX (US). He has made significant contributions to the field of medicinal chemistry, particularly in the development of nucleobase analogue derivatives. His work focuses on creating compounds that have the potential to treat various types of cancer.

Latest Patents

Lansakara-P holds a patent for "Nucleobase analogue derivatives and their applications." This patent discloses derivatives of nucleobase analogues that include a nucleobase moiety and an omega-3 polyunsaturated fatty acid moiety. The compounds also encompass pharmaceutically acceptable salts or prodrugs. Notably, the methods of using these compounds for the treatment of cancers, including pancreatic cancer, are also detailed in the patent. He has 1 patent to his name.

Career Highlights

Dharmika Lansakara-P is affiliated with the University of Texas System, where he continues to advance research in his field. His innovative approach to drug development has garnered attention and respect within the scientific community.

Collaborations

One of his notable collaborators is Zhengrong Cui, who is also a prominent figure in the research community. Their partnership exemplifies the collaborative spirit that drives innovation in scientific research.

Conclusion

Dharmika Lansakara-P is a notable inventor whose work on nucleobase analogue derivatives holds promise for cancer treatment. His contributions to the field are significant and reflect his dedication to advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…